Cargando…

198. Infective Endocarditis Among Solid Organ Transplant Recipients in the United States

BACKGROUND: With over 30,000 solid organ transplants (SOT) performed annually the United States alone, there is an urgent need to understand the risks and outcomes of infective endocarditis (IE) in SOT recipients. METHODS: We used data from the 2013–2017 Nationwide Readmissions Database (NRD). Hospi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichenberger, Emily, Dagher, Michael M, Fowler, Vance G, Federspiel, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776178/ http://dx.doi.org/10.1093/ofid/ofaa439.508

Ejemplares similares

1094. Infective Endocarditis During Index Hospitalization for Solid Organ Transplantation in the United States
por: Eichenberger, Emily, et al.
Publicado: (2020)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

36. Maternity-associated Infective Endocarditis in the United States: Similar Outcomes to Non-pregnant Patients
por: Dagher, Michael M, et al.
Publicado: (2020)

708. Infective Endocarditis Complicating Delivery in Pregnancy: Risk Factors, Complications, and Delivery Outcomes
por: Dagher, Michael M, et al.
Publicado: (2020)

156. Clinical Characteristics and Acute-phase Cytokine Response of Solid-Organ Transplant Recipients with Bloodstream Infections Differs According to Bacterial Type and Transplant Status
por: Eichenberger, Emily, et al.
Publicado: (2019)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

529. COVID-19 Antibody Responses in Solid Organ Transplant Recipients
por: Zervou, Fainareti, et al.
Publicado: (2020)

572. Antiviral Toxicities Among Pediatric Solid Organ Transplant Recipients
por: Downes, Kevin J, et al.
Publicado: (2020)

592. Antimicrobial Utilization in Solid Organ Transplant Recipients 12-Months Post-Transplantation
por: Parraga Acosta, Tommy J, et al.
Publicado: (2021)

918. Pilot Surveillance for Carbapenemase Gene-positive Organisms Among Hospitalized Solid Organ Transplant Recipients
por: Chan, June L, et al.
Publicado: (2020)

1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

1091. Incidence of Post-Transplant Lymphoproliferative Disorders among Epstein-Barr Virus Donor Positive, Recipient Negative Adult Solid Organ Transplant Recipients
por: Limaye, Abhijit P, et al.
Publicado: (2020)

540. Prolonged Viral Shedding of SARS-CoV-2 In Solid Organ Transplant Recipients
por: Nam, Hannah, et al.
Publicado: (2020)

884. Evaluation of Surgical Site Infections in Solid Organ Transplant Recipients with Beta-Lactam Allergies
por: Mowrer, Clayton, et al.
Publicado: (2020)

1103. Respiratory Virus Infections In Solid Organ Transplant Recipients: A Single Center Experience
por: Mendoza, Maria A, et al.
Publicado: (2020)

934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021)

198. Clinical Prediction of Bacteremia and the Need for Early Antibiotic Therapy in Solid Tumor Cancer Patients
por: Hyak, Jonathan M, et al.
Publicado: (2020)

1702. Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis
por: Yee, Jason, et al.
Publicado: (2020)

1096. Linezolid versus Tedizolid for the Treatment of Nontuberculous Mycobacteria in Solid Organ Transplant Recipients: An Assessment of Safety
por: Poon, Yi Kee, et al.
Publicado: (2020)

1083. Clinical Efficacy of Tedizolid for the Treatment of Mycobacterium abscessus complex Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2020)

1233. Serious Toxicities During Antimicrobial Therapy for Disseminated Nocardia Infection in Solid Organ Transplant Recipients
por: Saling, Christopher, et al.
Publicado: (2021)

1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
por: Friedman, Daniel, et al.
Publicado: (2019)

1101. Pulmonary Aspergillosis Complicating Non-Influenza Respiratory Virus Infections Among Solid Organ Transplant Recipients
por: Apostolopoulou, Anna, et al.
Publicado: (2020)

926. COVID-19 Infections After SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
por: Saharia, Kapil, et al.
Publicado: (2021)

310. Cryptococcal Infection Following COVID-19 infection in Solid Organ Transplant Recipients: A Case Series
por: Walker, Jeremey, et al.
Publicado: (2021)

479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
por: Zeitler, Kristen, et al.
Publicado: (2021)

1729. Profiling Human Neutrophil Functional Responses From Solid-Organ and Stem Cell Transplant Recipients to Candida albicans
por: Barros, Nicolas, et al.
Publicado: (2019)

2688. Characteristics of joint infections in solid organ transplant recipients
por: Abdow, Victor P, et al.
Publicado: (2023)

1703. Hematologic Toxicity of Valganciclovir Prophylaxis in Solid Organ Transplant Recipients as a Function of Weight-adjusted Ganciclovir Exposure
por: Campanella, Toni A, et al.
Publicado: (2020)

472. Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2: 2021 Update
por: Jandhyala, Deeksha, et al.
Publicado: (2021)

582. Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients
por: Fitzmaurice, Mary Grace, et al.
Publicado: (2020)

946. Epidemiology and Long-term Outcomes of BK Polyomavirus Nephropathy in Kidney Solid Organ Transplant Recipients at Texas Children’s Hospital
por: Deray, Kristen Valencia, et al.
Publicado: (2021)

Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017)

Use of a Sulfa Desensitization Protocol in Solid Organ Transplant Recipients
por: Kirsch, Denise, et al.
Publicado: (2017)

276. SARS-CoV-2 Infection in Solid Organ Transplant Candidates and Recipients at Texas Children’s Hospital: A Retrospective Review
por: Petters, Leanne, et al.
Publicado: (2021)

686. Elevations in TNFα and IL-18 are Associated with Increased Risk of Probable Cytomegalovirus Tissue Invasive Disease in Solid Organ Transplant Recipients
por: Karaba, Andrew H, et al.
Publicado: (2020)

Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma Elizabeth, et al.
Publicado: (2017)

1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
por: Sharova, Anna, et al.
Publicado: (2019)

1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients
por: Sun, Hsin-Yun, et al.
Publicado: (2019)

2715. Toxicities and clinical consequences of valganciclovir prophylaxis in solid organ transplant recipients
por: Lahoud, Chloe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d3mbna5k5rp92qnt5c1rgvd63s